Sugar Based Excipients Market

Sugar Based Excipients Market Size, Growth (2023-2028)

The global Sugar Based Excipients Market size was determined at USD 860.6 million in 2022, and it is predicted to expand up to USD 1.06 billion by 2028 at a CAGR of 4.3% over the conjecture period. The growth of this market is mainly credited to the increased use of co-processed excipients.

Market Overview:

Excipients are substances that are used in medications for proper administration and are inactive ingredients that are used to support the active ingredients of medicine and provide bulky solid formulations and long stability. These products exist in different forms like gums. Starch and syrup etc. This also reduces the viscosity and improves the solubility of the entire drug. The excipients give the medicine a flavor and coat in different colors, making the medicine look different and provide texture. The excipients are unsuitable sugars and polymers, complex and even human starch and gelatin. Sugar-based excipients are the best-known type of excipients used as part of oral prescription medications. Particular attention is paid to the drugs considered for the bitter active ingredient in the trial. Sugar-based excipients are used in glycerol, sodium saccharin, sucrose, sorbitol, etc. They are primarily used for antibiotics and patient syrups.

Recent Developments in Sugar Based Excipients Industry:

• Roquette Group (France) has a wide range of products that have been shown to work mainly in the market for sugar-based excipients. The Roquette Group opened a pharmaceutical application advancement focus in Lestrem, France. This new center helped the company improve the development of excipients and active ingredients for the pharmaceutical industry.
• DFE Pharma (Germany) opened a new sales office in Shanghai, China, effectively meeting the growing demand for excipient products and services in China.

Sugar Based Excipients Market Growth:

A major factor contributing to the rapid growth of the global sugar-based excipients market is the expiry of major pharmaceutical patents.

REPORT COVERAGE:

Drivers:

The market for sugar-based excipients has grown significantly during the forecast period, as most medications that make oral medications are taken by special patients for children, so they like fewer medications. Depending on the form and testing of the drug, children and other patients are attractive and easy to see. Sugar-based excipients are easy to use and can be easily coated with tablets, making them suitable for most pharmaceutical industries. The ability of sugar-based excipients to be approved by regulatory authorities is acting as an impediment factor. The reach of generic drugs worldwide has become a major driver of market growth. Also, market growth has been driven by increased demand for new excipients due to the benefits of drug delivery and stability. Besides, the market is strengthening as the preference for orally disintegrating tablets increases and their development. As the elderly population and the number of pediatric patients increase, the demand for orally disintegrating tablets increases. Excipients are essential ingredients to improve general pharmaceutical activity and performance, which directly affect the properties of the pharmaceutical formulation. An adequate proportion of excipients can improve the shelf life and bioavailability of the formulation. They can also be used for drug delivery mechanisms, such as sustained-release and sustained-release drugs. Practicing mannitol in various dosage forms is the fastest-growing sugar-based excipient with different segments of sugar alcohol. The high adaptability of alcohol-based sugar excipients in new formulation technologies, such as orally disintegrating tablets, is another reason why the sugar segments will experience strong growth in the coming year.

Depending on the type of sugar-based excipient, granulated sugar-based excipients have a large share, as they are widely used in the pharmaceutical industry. The main factor in increasing the growth of the segment market is to increase the group of pediatric patients, and real sugars are mainly used in oral formulations due to their non-toxicity and negligible response to medications. Furthermore, the rapid growth of the generic market is driving growth in this sector. Currently, the company is working to optimize excipients in the formulation and delivery of medications. They are also involved in the development of such formulations. These factors are expected to greatly influence the development and commercialization of these products in the future. Sugar-based excipients are in high demand in oral drug manufacturing, pharmaceutical innovation, and manufacturing markets in the pharmaceutical industry, government agencies are investing in research to develop more innovative products, and the general pharmaceutical market is sugar-based excipients for pharmaceutical manufacturing. Sugar-based excipients are more secure for use in pharmaceuticals, and sweet tests are like most patients of various ages. Sugar-based excipients where these factors are used to cover the bite flavors that offer market opportunities.

Restraints:

While the market demand and need for sugar-based excipients may seem widespread, an increase in regulatory requirements leading to a lack of FDA-approved manufacturing sites is expected to hamper the growth of this market. Strict quality control procedures and price pressures faced by major players are the main challenges for this industry.

Sugar Based Excipients Market Segmentation Analysis:

By Type:                            

• Powders and granules      
• Crystal      
• Syrup        

By Product:                 

• Actual sugar           
• Sugar alcohol         
• Artificial sweeteners           

By Functionality:                           

• Filler          
• Diluent     
• Flavouring agent  
• Tonicity agent       

By Formulation:                            

• Oral           
• Topical     
• Parenteral  

Geographical Segmentation Analysis:

• North America - the United States and Canada
• Europe - United Kingdom, Spain, Germany, Italy, and France
• The Asia Pacific - India, Japan, China, Australia, Singapore, Malaysia, South Korea, New Zealand, and Southeast Asia
• Latin America  - Brazil, Argentina, Mexico, and Rest of LATAM
• The Middle East and Africa - Africa and Middle East (Saudi Arabia, UAE, Lebanon, Jordan, Cyprus)

Regional Analysis:

Regarding geography, the market for sugar-based excipients has been classified into North America, Latin America, Eastern Europe, Western Europe, Japan, Japan and Asia Pacific, excluding the Middle East and Africa. North America has the highest growth rate in the market, with most players in the region, focusing on the development and innovation of sugar-based excipients. The market for sugar-based excipients is expected to record healthy CAGR during the forecast period. As investments in factors such as drug development and generic drug production have increased, favorable government policies have led Eastern and Western Europe to dominate the market for sugar-based excipients. In terms of favorable policies such as governments in developing countries such as China, India, and Korea, and growth policies in the medical and pharmaceutical industries, low manufacturing cost is the expected advantage of the Asia-Pacific region, excluding Japan, and the growth rate of the market for sugar-based excipients. On the other hand, North and South America are experiencing constant growth. Europe is supposed to dominate the entire market for sugar-based excipients throughout the outlook period. Most of it is due to the presence of major pharmaceutical companies and the use of advanced medical technology to develop better treatments. Sugar-based excipients are the most common form of excipients used in oral medications. Particular attention is paid to medicines intended for children. It is widely used in sucrose, glycerol, sodium saccharin, sorbitol, etc., mainly antibiotics and cough syrup for children. In addition, increasing elderly and pediatric patients will surge the growth of the market in the region. Greater investment in drug development increased production of generic drugs, and favorable government initiatives in the region are other factors responsible for market growth.

Impact of Covid-19 on the Global Sugar-based Excipients Market:

The Covid-19 pandemic effect has been felt by almost industries across the world, but the case is different for the pharmaceutical sector. There has been a huge incline in pharmaceutical production due to the increasing call for drugs and medicines to combat the coronavirus. This trend is likely to increase the growth of the sugar-based excipients market in the coming years.

Key Players in the Market:

Major Key Players in the Global Sugar Based Excipients Market are

• Archer Daniels Midland Company
• The Lubrizol Corporation
• Ashland Inc
• Roquette Group
• Associated British Foods Plc
• Meggle AG
• Basf SE
• FMC Corporation
• Cargill
• Dfe Pharma
• Colorcon Inc.